Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Reckitt Benckiser Group PLC Director's Dealing 2019

Sep 3, 2019

4872_dirs_2019-09-03_ddadc779-8987-4fd2-808b-c03c608220ef.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0752L

Reckitt Benckiser Group PLC

03 September 2019

3 September 2019

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

DIRECTOR/PDMR SHAREHOLDING

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 2 September 2019 employees were granted options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan (the "Sharesave Plan") with an option price of £47.44. No consideration is payable for the grant of an option. The options are granted in conjunction with the entering into of a three- or five-year savings plan.

The Company announces that Laxman Narasimhan, Chief Executive Officer, and Adrian Hennah, Chief Financial Officer, each elected to participate in the 2019 offer under the Sharesave Plan. Laxman was granted an option over 379 Shares, which will become exercisable after three years, on 1 February 2023. Adrian was granted an option over 316 Shares, which will become exercisable after 5 years, on 1 February 2025.

The following notifications are made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Laxman Narasimhan

2

Reason for the notification

a)

Position/status

Executive Director - Chief Executive Officer

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan

c)

Price(s) and volume(s)

Price(s) Volume(s)
£47.44 379

d)

Aggregated information

-       Aggregated volume

-       Price

Price(s) Volume(s) Total
£47.44 379 £17,979.76

e)

Date of the transaction

2019-09-02

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adrian Hennah

2

Reason for the notification

a)

Position/status

Executive Director - Chief Financial Officer

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Grant of options under the Reckitt Benckiser Group 2015 Savings Related Share Option Plan

c)

Price(s) and volume(s)

Price(s) Volume(s)
£47.44 316

d)

Aggregated information

-       Aggregated volume

-       Price

Price(s) Volume(s) Total
£47.44 316 £14,991.04

e)

Date of the transaction

2019-09-02

f)

Place of the transaction

Outside a trading venue

For further Information:

Christine Logan

Deputy Company Secretary

Tel +44 (0) 1753 217 800

About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit www.rb.com

*RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBBGDCDXGBGCX